GLP-1 medications like Ozempic and Wegovy are rapidly reshaping consumer eating habits across the Americas, fueling demand for healthier, high-protein, and lower-calorie foods.
As Sarah Nolet outlines in a recent piece, this isn’t a distant trend, it’s already impacting the food system. Insights from the BMO Global Farm to Market Conference echo the urgency: food companies and ingredient suppliers must prepare for a dramatic shift in protein demand.
At White River Nutrition, we see this as a clear call to action. We are positioned to meet the growing need for high-quality, soy-based protein and oil, supporting healthier diets with scalable, sustainable solutions.
Read “GLP-1s Are Reshaping the Food System — are midstream companies ready?” by Sarah Nolet